270 related articles for article (PubMed ID: 26161839)
1. Neurotoxicity associated with exposure to 1-bromopropane in golf-club cleansing workers.
Wang TH; Wu ML; Wu YH; Tsai WJ; Lin KP; Wang CL; Yang CC; Deng JF
Clin Toxicol (Phila); 2015; 53(8):823-6. PubMed ID: 26161839
[TBL] [Abstract][Full Text] [Related]
2. Bromide and N-acetyl-S-(n-propyl)-L-cysteine in urine from workers exposed to 1-bromopropane solvents from vapor degreasing or adhesive manufacturing.
Hanley KW; Petersen MR; Cheever KL; Luo L
Int Arch Occup Environ Health; 2010 Jun; 83(5):571-84. PubMed ID: 20229238
[TBL] [Abstract][Full Text] [Related]
3. Globin s-propyl cysteine and urinary N-acetyl-S-propylcysteine as internal biomarkers of 1-bromopropane exposure.
Valentine H; Amarnath K; Amarnath V; Li W; Ding X; Valentine WM; Ichihara G
Toxicol Sci; 2007 Aug; 98(2):427-35. PubMed ID: 17517825
[TBL] [Abstract][Full Text] [Related]
4. Comparison and evaluation of urinary biomarkers for occupational exposure to spray adhesives containing 1-bromopropane.
Mathias PI; Cheever KL; Hanley KW; Marlow KL; Johnson BC; B'hymer C
Toxicol Mech Methods; 2012 Sep; 22(7):526-32. PubMed ID: 22519856
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-S-(n-propyl)-l-cysteine in urine from workers exposed to 1-bromopropane in foam cushion spray adhesives.
Hanley KW; Petersen MR; Cheever KL; Luo L
Ann Occup Hyg; 2009 Oct; 53(7):759-69. PubMed ID: 19706636
[TBL] [Abstract][Full Text] [Related]
6. Urinary bromide and breathing zone concentrations of 1-bromopropane from workers exposed to flexible foam spray adhesives.
Hanley KW; Petersen M; Curwin BD; Sanderson WT
Ann Occup Hyg; 2006 Aug; 50(6):599-607. PubMed ID: 16698849
[TBL] [Abstract][Full Text] [Related]
7. Neurologic illness associated with occupational exposure to the solvent 1-bromopropane--New Jersey and Pennsylvania, 2007-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1300-2. PubMed ID: 19052528
[TBL] [Abstract][Full Text] [Related]
8. A survey on exposure level, health status, and biomarkers in workers exposed to 1-bromopropane.
Ichihara G; Li W; Ding X; Peng S; Yu X; Shibata E; Yamada T; Wang H; Itohara S; Kanno S; Sakai K; Ito H; Kanefusa K; Takeuchi Y
Am J Ind Med; 2004 Jan; 45(1):63-75. PubMed ID: 14691970
[TBL] [Abstract][Full Text] [Related]
9. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide).
Majersik JJ; Caravati EM; Steffens JD
Clin Toxicol (Phila); 2007; 45(3):270-6. PubMed ID: 17453879
[TBL] [Abstract][Full Text] [Related]
10. Development of an HPLC-MS procedure for the quantification of N-acetyl-S-(n-propyl)-l-cysteine, the major urinary metabolite of 1-bromopropane in human urine.
Cheever KL; Marlow KL; B'hymer C; Hanley KW; Lynch DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(8-9):827-32. PubMed ID: 19237326
[TBL] [Abstract][Full Text] [Related]
11. DNA damage in leukocytes of workers occupationally exposed to 1-bromopropane.
Toraason M; Lynch DW; DeBord DG; Singh N; Krieg E; Butler MA; Toennis CA; Nemhauser JB
Mutat Res; 2006 Jan; 603(1):1-14. PubMed ID: 16412685
[TBL] [Abstract][Full Text] [Related]
12. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
Spee T; van Valen E; van Duivenbooden C; van der Laan G
Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
[TBL] [Abstract][Full Text] [Related]
13. Neuro-reproductive toxicities of 1-bromopropane and 2-bromopropane.
Ichihara G
Int Arch Occup Environ Health; 2005 Mar; 78(2):79-96. PubMed ID: 15812677
[TBL] [Abstract][Full Text] [Related]
14. A case of severe neurotoxicity associated with exposure to 1-bromopropane, an alternative to ozone-depleting or global-warming solvents.
Samukawa M; Ichihara G; Oka N; Kusunoki S
Arch Intern Med; 2012 Sep; 172(16):1257-60. PubMed ID: 22893012
[TBL] [Abstract][Full Text] [Related]
15. Detecting chronic solvent encephalopathy in occupations at risk.
Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
[TBL] [Abstract][Full Text] [Related]
16. New approach to risk assessment of central neurotoxicity induced by 1-bromopropane using animal models.
Fueta Y; Ishidao T; Ueno S; Yoshida Y; Kunugita N; Hori H
Neurotoxicology; 2007 Mar; 28(2):270-3. PubMed ID: 16782201
[TBL] [Abstract][Full Text] [Related]
17. [Neurotoxicity of organic solvents--recent findings].
Matsuoka M
Brain Nerve; 2007 Jun; 59(6):591-6. PubMed ID: 17585590
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of exposure and effect in the serum and urine of rats or workers exposed to 1-bromopropane.
Zhang Y; Xiao J; Lv J; Chen X; Li Y; Yang H; Miao Q; Wuhan B; Gao W; Li B
Toxicol Ind Health; 2022 Jun; 38(6):351-364. PubMed ID: 35532359
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane.
Li W; Shibata E; Zhou Z; Ichihara S; Wang H; Wang Q; Li J; Zhang L; Wakai K; Takeuchi Y; Ding X; Ichihara G
J Occup Environ Med; 2010 Aug; 52(8):769-77. PubMed ID: 20657306
[TBL] [Abstract][Full Text] [Related]
20. Reducing workplace exposure to 1-bromopropane.
Chalupka S
Workplace Health Saf; 2014 Mar; 62(3):128. PubMed ID: 24601960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
